Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
28-week extension evaluating long-term safety of vildagliptin vs placebo in type 2 diabetes with moderate or severe renal insufficiency
2008-001243-18Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and Renal Insufficiency (RI) comparing Vildagliptin arm with Placebo arm (2 arms). Started Jul 2008; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)Renal Insufficiency (RI)
Beyond the preview
Go deeper on 2008-001243-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001243-18.